The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer

OBJECTIVE: Immunotherapy for esophageal cancer is relatively novel but increasingly used. This study evaluated the early use of immunotherapy as an adjunct to neoadjuvant chemoradiotherapy before esophagectomy for locally advanced disease. METHODS: Perioperative morbidity (composite of mortality, ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Lye-Yeng, Liou, Douglas Z., Backhus, Leah M., Lui, Natalie S., Shrager, Joseph B., Berry, Mark F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Thoracic: Esophageal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328967/
https://www.ncbi.nlm.nih.gov/pubmed/37425457
http://dx.doi.org/10.1016/j.xjon.2023.03.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328967/
https://www.ncbi.nlm.nih.gov/pubmed/37425457
http://dx.doi.org/10.1016/j.xjon.2023.03.015

Ejemplares similares